Search research articles
Contact Us
Filters
Showing results (101-110 of 290) with videos related to
Page
of 29
Sort By:
Acta Clinica Belgica
|
January 1, 1992
A randomized placebo controlled trial on the effects of simvastatin, a HMG-CoA reductase inhibitor, on blood lipids and fibrinolytic parameters
H Jacobs, F Van de Werf, E Lesaffre, et al.
European Heart Journal
|
August 1, 1987
Treatment of prosthetic tricuspid valve thrombosis with recombinant tissue-type plasminogen activator
P Cambier, P Mombaerts, H De Geest, et al.
Journal of the American College of Cardiology
|
March 1, 1992
Present status of rescue coronary angioplasty: current polarization of opinion and randomized trials
S G Ellis, F Van de Werf, E Ribeiro-daSilva, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 27, 2005
TAFI levels in patients with acute myocardial infarction treated with thrombolysis
C Frere, S Renard, A Gils, et al.
Pacing and Clinical Electrophysiology : PACE
|
December 1, 1996
Heart rate variability after cardiac transplantation in humans
D Ramaekers, H Ector, J Vanhaecke, et al.
Acta Cardiologica
|
December 8, 1998
Primary balloon dilatation in coarctation of the aorta complicated by severe aortic insufficiency
C De Meester, W Budts, M Gewillig, et al.
European Heart Journal
|
October 29, 1998
Heart rate variability and heart rate in healthy volunteers. Is the female autonomic nervous system cardioprotective?
D Ramaekers, H Ector, A E Aubert, et al.
Circulation
|
May 1, 1986
The mechanism of disappearance of the physiologic third heart sound with age
F Van de Werf, J Geboers, H Kesteloot, et al.
The American Journal of Cardiology
|
December 1, 1979
Calibration of left ventricular apexcardiogram
F Van de Werf, B Denef, A Aubert, et al.
Journal of the American College of Cardiology
|
April 1, 1993
Combined thromboxane A2 synthase inhibition and prostaglandin endoperoxide receptor antagonism limits myocardial infarct size after mechanical coronary occlusion and reperfusion at doses enhancing coronary thrombolysis by streptokinase
G Vandeplassche, C Hermans, Y Somers, et al.
Page
of 29
Search research articles
Search
Showing results (101-110 of 290) with videos related to
Sort By:
Page
of 29
Acta Clinica Belgica
|
January 1, 1992
A randomized placebo controlled trial on the effects of simvastatin, a HMG-CoA reductase inhibitor, on blood lipids and fibrinolytic parameters
H Jacobs, F Van de Werf, E Lesaffre, et al.
European Heart Journal
|
August 1, 1987
Treatment of prosthetic tricuspid valve thrombosis with recombinant tissue-type plasminogen activator
P Cambier, P Mombaerts, H De Geest, et al.
Journal of the American College of Cardiology
|
March 1, 1992
Present status of rescue coronary angioplasty: current polarization of opinion and randomized trials
S G Ellis, F Van de Werf, E Ribeiro-daSilva, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 27, 2005
TAFI levels in patients with acute myocardial infarction treated with thrombolysis
C Frere, S Renard, A Gils, et al.
Pacing and Clinical Electrophysiology : PACE
|
December 1, 1996
Heart rate variability after cardiac transplantation in humans
D Ramaekers, H Ector, J Vanhaecke, et al.
Acta Cardiologica
|
December 8, 1998
Primary balloon dilatation in coarctation of the aorta complicated by severe aortic insufficiency
C De Meester, W Budts, M Gewillig, et al.
European Heart Journal
|
October 29, 1998
Heart rate variability and heart rate in healthy volunteers. Is the female autonomic nervous system cardioprotective?
D Ramaekers, H Ector, A E Aubert, et al.
Circulation
|
May 1, 1986
The mechanism of disappearance of the physiologic third heart sound with age
F Van de Werf, J Geboers, H Kesteloot, et al.
The American Journal of Cardiology
|
December 1, 1979
Calibration of left ventricular apexcardiogram
F Van de Werf, B Denef, A Aubert, et al.
Journal of the American College of Cardiology
|
April 1, 1993
Combined thromboxane A2 synthase inhibition and prostaglandin endoperoxide receptor antagonism limits myocardial infarct size after mechanical coronary occlusion and reperfusion at doses enhancing coronary thrombolysis by streptokinase
G Vandeplassche, C Hermans, Y Somers, et al.
Page
of 29